project id: TCGA-PRAD; case submitter id: TCGA-EJ-8470; selected normal wgs: true; state: released; age at index: 58; days to birth: -21209; ethnicity: not reported; gender: male; race: black or african american; vital status: Alive; year of birth: 1952; age at diagnosis: 21209; ajcc clinical m: M0; ajcc clinical t: T2c; ajcc pathologic n: N0; ajcc pathologic t: T2c; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1159.0; icd 10 code: C61; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; primary gleason grade: Pattern 4; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; secondary gleason grade: Pattern 3; site of resection or biopsy: Prostate gland; synchronous malignancy: No; tissue or organ of origin: Prostate gland; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 13.0; intermediate dimension: 1.6; longest dimension: 1.9; preservation method: Unknown; shortest dimension: 0.4; sample id: faddb560-8baf-4555-a43e-dd8f20efb3f5; sample submitter id: TCGA-EJ-8470-01A; portion id: fe7ae8e1-be7f-4f47-ab86-f2d415d13c50; portion submitter id: TCGA-EJ-8470-01A-11; slide id: 0d28ddd8-fe12-4fcd-919c-3a9150798847; slide submitter id: TCGA-EJ-8470-01A-01-TS1; percent necrosis: 0.0; percent normal cells: 15.0; percent stromal cells: 10.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0; section location: TOP;